Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-05-16 | KEATING LAURIE | - | Buy | 7,000 | $5.00 | $35,000.00 | +100.0% | → |
| 2022-05-12 | Amin Biren | CFO, TREASURER | Buy | 1,000 | $4.42 | $4,420.00 | +14.5% | → |
| 2022-03-23 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 3,000 | $8.02 | $24,060.00 | +0.1% | → |
| 2022-03-23 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | 1,050 | $7.91 | $8,305.50 | +0.3% | → |
| 2022-03-22 | Barrett Scott | CHIEF MEDICAL OFFICER | Buy | 900 | $7.49 | $6,736.50 | +13.5% | → |
| 2022-03-15 | Feinberg Peter | - | Buy | 6,667 | $6.75 | $45,002.25 | +130.8% | → |
| 2022-03-15 | BERMAN ANN E | - | Buy | 6,000 | $6.40 | $38,400.00 | +171.4% | → |
| 2021-09-20 | Feinberg Peter | - | Buy | 4,750 | $24.45 | $116,113.75 | +1,361% | → |
| 2021-09-13 | Feinberg Peter | - | Buy | 6,099 | $21.50 | $131,113.70 | +1.6% | → |
| 2021-09-13 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | 2,083 | $22.87 | $47,631.96 | - | → |
| 2021-08-03 | Cormorant Asset Management, LP | - | Buy | 550,000 | $15.00 | $8,250,000.00 | +32.3% | → |
| 2021-08-03 | Feinberg Peter | - | Buy | 291,667 | $15.00 | $4,375,005.00 | +42.5% | → |
| 2021-08-03 | Zeskind Benjamin J. | President and CEO | Buy | 2,098 | $15.00 | $31,470.00 | - | → |
| 2021-08-03 | KEATING LAURIE | - | Buy | 7,000 | $15.00 | $105,000.00 | New | → |
| 2021-08-03 | Hall Brett Matthew | Chief Scientific Officer | Buy | 1,353 | $15.00 | $20,295.00 | +26.8% | → |
| 2021-08-03 | CARPENTER ROBERT J | - | Buy | 325,000 | $15.00 | $4,875,000.00 | +39.4% | → |
| 2021-08-03 | Bookman Michael | General Counsel and Secretary | Buy | 1,402 | $15.00 | $21,030.00 | New | → |
| 2021-08-03 | BERMAN ANN E | - | Buy | 3,500 | $15.00 | $52,500.00 | New | → |
| 2021-08-03 | Barrett Scott | Chief Medical Officer | Buy | 667 | $15.00 | $10,005.00 | +11.1% | → |
| 2021-08-03 | Amin Biren | CFO, Treasurer | Buy | 4,175 | $15.00 | $62,625.00 | +153.3% | → |